Platform
Home
Screener
Copilot
AskEdgar Studio
New
Back
Bright Minds Biosciences Inc.
DRUG · SEC Filings
website
26
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives o...
Price
24.11
Market Cap
240.86 M
Float
8.21 M
Country
US
Sector
Healthcare
Exchange
NASDAQ
Overview
Filings
Insights
Dilution
News
Transcripts
Search in Documents
Open in Studio
Studio
Login
Ask about DRUG
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
All
Chronological
Financials
Registrations
Prospectus
News
Proxies
Ownerships
Other
Bright Minds Biosciences Inc.
DRUG · SEC Filings
8.21 M
Float
24.11
Price
240.86 M
Market Cap
Financials
TYPE
HEADLINE
FILED AT
News
TYPE
HEADLINE
FILED AT
6-K
Bright Minds Biosciences Provides Update About Planned Study with BMB-101 in Developmental and Epileptic Encephalopathies
Nov 2, 2026
6-K
Bright Minds Biosciences Inc. Announces Annual General Meeting Voting Results
Oct 2, 2026
6-K
Bright Minds Biosciences to Participate in 2026 FPWR Research Symposium and PWS Family Conference
Sep 30, 2026
6-K
Bright Minds Biosciences Inc. Condensed Interim Consolidated Financial Statements for the Nine Months Ended June 30, 2026
Aug 14, 2026
6-K
Bright Minds Biosciences Inc. Announces Annual General Meeting of Shareholders
Jun 3, 2026
6-K
Bright Minds Biosciences Inc. Announces Annual General Meeting
Jun 2, 2026
Prospectus
TYPE
HEADLINE
FILED AT
424B5
REGISTERED OFFERING
Jan 8, 2026
424B5
SHELF OFFERING | Offering amount: $100,000,000 | Bank: Jefferies, TD Cowen, Piper Sandler, Cantor
Jan 6, 2026
424B3
Form 424B3 - Prospectus [Rule 424(b)(3)]
Feb 14, 2025
Registrations
TYPE
HEADLINE
FILED AT
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 12, 2026
FWP
Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jan 7, 2026
FWP
Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jan 6, 2026
F-3
August 2025 SHELF & ATM
Aug 25, 2025
F-3
Form F-3 - Registration statement by foreign private issuers
Feb 5, 2025
D
Form D - Notice of Exempt Offering of Securities - Item 06b
Nov 19, 2024
Proxies
TYPE
HEADLINE
FILED AT
Ownerships
TYPE
HEADLINE
FILED AT
Chronological
TYPE
HEADLINE
FILED AT
Other
TYPE
HEADLINE
FILED AT